Short-Term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State.
Jiwon KimHee Jeong JangDawid SchellingerhoutSu-Kyoung LeeHa KimYoung Dae KimKyung-Yul LeeHye-Yeon ChoiHan-Jin ChoSeong-Soo JangSangmin JeonIck Chan KwonKwangmeyung KimWi-Sun RyuMatthias NahrendorfSeungbum ChoiDong-Eog KimPublished in: Annals of neurology (2020)
We provide the first preclinical evidence that a rebound prothrombotic state follows short-term cessation of dabigatran therapy. ANN NEUROL 2021;89:444-458.